VentriPoint Diagnostics (CVE:VPT) Trading Up 20.8% – Here’s Why

VentriPoint Diagnostics Ltd. (CVE:VPT)’s stock price shot up 20.8% during trading on Wednesday . The stock traded as high as C$0.16 and last traded at C$0.15. 494,509 shares were traded during trading, an increase of 199% from the average session volume of 165,149 shares. The stock had previously closed at C$0.12.

VentriPoint Diagnostics Trading Up 25.0%

The stock has a market capitalization of C$25.16 million, a P/E ratio of -5.00 and a beta of -0.41. The business has a 50 day simple moving average of C$0.10 and a 200-day simple moving average of C$0.11. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28.

About VentriPoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.